Stories by Chris Leamon

Dr. Chris Leamon has nearly two decades of experience in the biopharmaceutical industry and is currently the vice president of research and development at Endocyte, a company developing targeted therapies and companion imaging diagnostics for the treatment of cancer and other serious diseases. Prior to joining Endocyte, Dr. Leamon conducted discovery research for GlaxoWellcome and Isis Pharmaceuticals. He holds a doctorate in biochemistry from Purdue University and a bachelor's degree in chemistry from Baldwin-Wallace College.